Zhenjie Chen
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Xiaozheng Anshen Formula alleviates podocyte injury in diabetic kidney disease by restoring autophagy flux via inhibiting TRPC6-mediated calcium signaling.
Journal: Journal of ethnopharmacology
Published: January 11, 2026
When Obesity Hits the Kidneys: Sex-Specific Effects of Visceral Adiposity Indices on Diabetic Kidney Disease Risk.
Journal: Journal of nutrition and metabolism
Published: November 24, 2025
Intravenous iron therapy for patients with heart failure: a meta-analysis stratified by chronic kidney disease status.
Journal: BMC cardiovascular disorders
Published: November 07, 2025
Low-dose cyclophosphamide combined with chinese herbal medicine Shuli Fenxiao formula for the treatment of intermediate-to-high risk primary membranous nephropathy.
Journal: Frontiers in immunology
Published: December 11, 2024
The significance of subclassifying focal segmental glomerulosclerosis lesions (S1) in IgA nephropathy.
Journal: Kidney international
Published: April 30, 2024
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis.
Journal: The New England journal of medicine
Published: March 20, 2024
Critical role of FGF21 in diabetic kidney disease: from energy metabolism to innate immunity.
Journal: Frontiers in immunology
Published: November 05, 2023
Efficacy and safety of non-steroidal mineralocorticoid receptor antagonists for renal outcomes: A systematic review and meta-analysis.
Journal: Diabetes research and clinical practice
Published: October 01, 2022
Efficacy and safety of artesunate for patients with IgA nephropathy: a study protocol for a multicenter, double-blind, randomized, placebo-controlled trial.
Journal: Trials
Published: March 23, 2021
Statins can benefit patients with primary membranous nephropathy on venous thromboembolism.
Journal: Renal failure
Published: February 15, 2021
Last Updated: 09/26/2026